VITA 34 International AG: VITA 34 plans further growth in 2011 and international expansion
VITA 34 International AG / Key word(s): Final Results
24.03.2011 09:31
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
VITA 34 International AG: VITA 34 plans further growth in 2011 and
international expansion
- Sales forecast of more than 18m Euro for 2011
- Marked improvement of profitability expected
- Entry in the Slovakian market scheduled for 2011
- Confirmation of the preliminary figures for 2010
Leipzig, March 24, 2011 - The VITA 34 International AG (ISIN DE000A0BL849),
parent company of the oldest umbilical cord blood bank for individual
provision in Europe, VITA 34 AG, wants to continue its growth in the
current business year 2011 and aims at increasing the revenue from
approximately 17m Euro in 2010 to more than 18m Euro. It is also intended
to further increase the number of storages. With 11,038 umbilical cord
blood storages in the expired period under review 2010, VITA 34 has
achieved the highest number of storages ever in the company's history.
Furthermore, the company confirms the published preliminary figures for the
business year 2010.
VITA 34 also plans to considerably improve the profitability in 2011. In
2010, the company had already increased the earnings before interest and
taxes (EBIT) to 0.7m Euro from 0.2m Euro in the year before. This results
in an EBIT margin of 4.4 percent. In the medium term, this margin is to be
increased to a minimum of 10 percent.
The successful international sales, which account for about one third of
the storages, contribute to the company's growth. The principal share is
generated on the Spanish market, in which VITA 34 is represented by its
subsidiary Secuvita, S. L.
Through cooperations, VITA 34 is also actively operating in Italy,
Slovenia, and in Switzerland. In order to secure future potentials for
growth, VITA 34 wants to develop the international business and expand in
Slovakia still in 2011. Some 60,000 babies are born each year in Slovakia.
This market is attractive, among other things, because of the low degree of
competition and is to additionally contribute to the operating income in
the medium term already.
The complete annual report is available for download on
www.vita34group.com.
Press / Investor Relations:
Axel Mühlhaus
Dr. Sönke Knop
edicto GmbH
Eschersheimer Landstr. 42
D-60322 Frankfurt a.M.
Phone: +49 (069) 90550550
Fax: +49 (069) 90550577
E-mail: vita34@edicto.de
24.03.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: VITA 34 International AG
Deutscher Platz 5a
04103 Leipzig
Deutschland
Phone: +49(0341)48792-40
Fax: +49(0341)48792-39
E-mail: info@vita34.de
Internet: www.vita34.de
ISIN: DE000A0BL849
WKN: A0BL84
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, München, Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
